Contrary to this review, a clinical study in patients with breast cancer indicated lower plasma high-sensitivity C-reactive protein and maintaining CD4+ T lymphocytes in the experimental group with fish oil enriched in EPA and DHA supplementation for 30 days compared to a control group whose CD4+ lymphocytes significantly decreased [31]. The gene discussed is CD4; the disease is breast carcinoma.